Pharmaceutical AI investment is projected to grow sixfold by 2030, yet regulatory affairs remains stuck with tools built for entirely different problems. Regulatory tasks carry enormous administrative weight and demand expertise that generic AI isn't built to handle.
This is where agentic AI changes the equation.
As Sudhir Kandarth, CRO & VP, Freyr Solutions puts it: "Trust isn't declared. It's engineered." Click here to read the article.